Highlights and Quick Summary
- Operating Income Growth for the quarter ending August 31, 2022 was 55.18% (a 172.22% increase compared to previous quarter)
- Year-over-year quarterly Operating Income Growth increased by 12.57%
- Annual Operating Income Growth for 2022 was 53.15% (a 60.57% increase from previous year)
- Annual Operating Income Growth for 2021 was 33.1% (a -101.22% decrease from previous year)
- Annual Operating Income Growth for 2020 was -2715.37% (a 3076.24% increase from previous year)
- Twelve month Operating Income Growth ending August 31, 2022 was 53.15% (a 5.88% increase compared to previous quarter)
- Twelve month trailing Operating Income Growth increased by 1.63% year-over-year
Trailing Operating Income Growth for the last four month:
| 31 Aug '22 | 31 May '22 | 28 Feb '22 | 30 Nov '21 |
|---|---|---|---|
| 53.15% | 50.2% | 69.28% | 52.3% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Income Growth of Organigram Holdings Inc.
Most recent Operating Income Growthof OGI including historical data for past 10 years.Interactive Chart of Operating Income Growth of Organigram Holdings Inc.
Organigram Holdings Inc. Operating Income Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 55.18% | 20.27% | 69.35% | – | 53.15% |
| 2021 | 49.02% | 46.62% | 86.29% | -651.51% | 33.1% |
| 2020 | -18492.96% | -59.52% | -743.93% | -130.32% | -2715.37% |
| 2019 | -99.67% | -953.1% | 88.15% | 56.58% | -85.49% |
| 2018 | 30243.69% | 111.72% | – | – | 589.03% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic